Observational studyDiabetologia2026

Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes.

Kagan E Karakus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.